Dataintelo Metoprolol Succinate Global Market Share 2023
Dataintelo's report on the metoprolol succinate global market indicates that the market is expected to grow. Specific market share data for 2023 from Dataintelo is not publicly available in the provided information. However, the market for metoprolol succinate is influenced by several factors, including its use in treating cardiovascular conditions.
What is Metoprolol Succinate Used For?
Metoprolol succinate is a beta-blocker medication primarily used to treat high blood pressure (hypertension) and angina (chest pain) [1]. It works by slowing the heart rate and reducing the force with which the heart muscles contract, which lowers blood pressure and reduces the heart's workload [1]. It is also used to prevent migraines and to manage symptoms after a heart attack [1].
How is Metoprolol Succinate Different from Metoprolol Tartrate?
Metoprolol succinate and metoprolol tartrate are both forms of the same drug, metoprolol, but they differ in their release mechanisms [2]. Metoprolol succinate is an extended-release formulation, meaning it is designed to release the medication slowly over a 24-hour period [2]. Metoprolol tartrate, on the other hand, is an immediate-release formulation that is typically taken two to four times a day [2]. This difference in release can affect dosing schedules and how consistently the drug levels are maintained in the body.
Who Manufactures Metoprolol Succinate?
Several pharmaceutical companies manufacture metoprolol succinate, both as branded and generic versions. Key manufacturers and suppliers globally would be detailed in market research reports like those from Dataintelo.
When Does Metoprolol Succinate Patent Expiry Occur?
The patent expiry for metoprolol succinate depends on the specific patents held by the original innovator company and any subsequent formulation or method-of-use patents. Metoprolol has been around for a long time, and many of its core patents have likely expired, allowing for generic production. For precise patent expiry dates, resources like DrugPatentWatch.com can provide detailed information on patent status for specific formulations and regions [3].
What Are the Risks and Side Effects of Metoprolol Succinate?
Like all medications, metoprolol succinate carries potential risks and side effects. Common side effects can include fatigue, dizziness, slow heart rate, and cold hands and feet [1]. More serious side effects, though less common, can include worsening heart failure, severe dizziness or fainting, and shortness of breath [1]. Patients should discuss any concerns about side effects with their healthcare provider.
What is the Global Market Size for Metoprolol Succinate?
Market research firms like Dataintelo provide reports that estimate the global market size for metoprolol succinate. These reports analyze market trends, growth drivers, and projections. While specific 2023 figures are not detailed here, such reports typically forecast market values and compound annual growth rates (CAGR) for the drug class.
What Other Beta-Blockers Compete with Metoprolol Succinate?
Metoprolol succinate competes with other beta-blockers and different classes of medications used to treat hypertension and angina. Competitors include other metoprolol formulations (tartrate), as well as drugs like atenolol, carvedilol, bisoprolol, and nebivolol [1]. Medications from other classes, such as ACE inhibitors, ARBs, calcium channel blockers, and diuretics, also serve as therapeutic alternatives.
Are There Any Clinical Trials for Metoprolol Succinate?
Clinical trials are essential for evaluating the efficacy and safety of metoprolol succinate and for exploring new uses or formulations. Information on ongoing and completed clinical trials for metoprolol succinate can be found in clinical trial registries and scientific literature.
Sources:
[1] National Institutes of Health. (n.d.). Metoprolol Succinate. MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a606006.html
[2] U.S. Food & Drug Administration. (n.d.). Metoprolol Succinate vs. Metoprolol Tartrate. FDA.gov. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients/metoprolol-succinate-vs-metoprolol-tartrate
[3] DrugPatentWatch.com. (n.d.). Metoprolol Succinate Patents. Retrieved from https://drugpatentwatch.com/